Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of acute pulmonary embolism: a propensity-matched analysis of 478 patients

30 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Acute heart failure Acute heart failure (management) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo

Hospital de Santa Cruz, Carnaxide (Portugal)

51 More presentations in this session

Presentation thumbnail
Professor A. Babaeva (Volgograd, RU)
Presentation thumbnail
Doctor H. Kataoka (Saiki, JP)
Presentation thumbnail
Doctor V. kittipibul (Durham, US)
Presentation thumbnail
Doctor T. Taeger (Heidelberg, DE)
Presentation thumbnail
Doctor H. de Barros Viegas (Setubal, PT)

ESC 365 is supported by

ESC 365 is supported by